Immune Responses in Wild-type Mice Against Prion Proteins Induced Using a DNA Prime-Protein Boost Strategy

被引:0
作者
HAN YanLing LI Yuan SONG Juan WANG Ying SHI Qi CHEN Cao ZHANG BaoYun GUO Yan LI ChaoPing HAN Jun and DONG XiaoPing State Key Laboratory for Infectious Disease Prevention and ControlNational Institute for Viral Disease Control and PreventionChinese Center for Disease Control and PreventionBeijing China Medical SchoolAnhui University of Science and TechnologyHuainan China [1 ,2 ,1 ,1 ,2 ,1 ,2 ,1 ,1 ,1 ,1 ,2 ,1 ,1 ,1 ,102206 ,2 ,231001 ]
机构
关键词
Prion; DNA vaccine; Humoral response; T‐cell response; Prime‐boosting regime;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objective To break immune tolerance to prion (PrP) proteins using DNA vaccines.Methods Four different human prion DNA vaccine candidates were constructed based on the pcDNA3.1 vector:PrP‐WT expressing wild‐type PrP,Ubiq‐PrP expressing PrP fused to ubiquitin,PrP‐LII expressing PrP fused to the lysosomal integral membrane protein type II lysosome‐targeting signal,and PrP‐ER expressing PrP locating the ER.Using a prime‐boost strategy,three‐doses of DNA vaccine were injected intramuscularly into Balb/c mice,followed by two doses of PrP protein.Two weeks after the last immunization,sera and spleens were collected and PrP‐specific humoral and cellular immune responses evaluated by ELISA and ELISPOT tests.Results Higher levels of serum PrP antibodies were detected in mice vaccinated using the strategy of DNA priming followed by protein boosting.Of these,WT‐PrP,Ubiq‐PrP,and PrP‐LII induced significantly higher humoral responses.ELISPOT tests showed markedly increased numbers of IFN‐γ‐secreting T cells in mice vaccinated using the strategy of DNA priming followed by protein boosting after stimulation with recombinant PrP23‐90 and PrP23‐231.PrP‐ER inducedthe strongest T‐cell response.Conclusion Prion vaccines can break tolerance to PrP proteins and induce PrP‐specific humoral and cellular immune responses.
引用
收藏
页码:523 / 529
页数:7
相关论文
共 16 条
[1]  
Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells. Cole GA. Methods in Molecular Biology . 2005
[2]   A novel anti-prion protein monoclonal antibody and its single-chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells [J].
Shimizu, Yoshihisa ;
Kaku-Ushiki, Yuko ;
Iwamaru, Yoshifumi ;
Muramoto, Tamaki ;
Kitamoto, Tetsuyuki ;
Yokoyama, Takashi ;
Mohri, Shirou ;
Tagawa, Yuichi .
MICROBIOLOGY AND IMMUNOLOGY, 2010, 54 (02) :112-121
[3]  
A lphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Leitner W W,Hwang L N,Deveer M J,et al. Nature Medicine . 2003
[4]  
MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells. Basha G,Lizee G,Reinicke AT,Seipp RP,Omilusik KD,Jefferies WA. PLoS ONE . 2008
[5]  
Antigen-loaded ER microsomes from APC induce potent immune responses against viral infection. Sofra V,Mansour S,Liu M,et al. European Journal of Immunology . 2009
[6]  
Cytosolic prion protein in-duces apoptosisin human neuronal cell SH-SY5Yvia mitochon-drial disruption pathway. Wang X,Dong CF,Shi Q,et al. BMB Rep . 2009
[7]  
Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Anthony R White,Perry Enever,Mourad Tayebi,Simon Hawke, et al. Nature . 2003
[8]  
Study on interaction between microtubule associated protein tau and prion protein[J]. HAN Jun1,ZHANG Jin1,2,YAO Hailan1,3,WANG Xiaofan1,LI Feng1,CHEN Lan1,4,GAO Chen1,GAO Jianmei1,NIE Kai1,ZHOU Wei1 & DONG Xiaoping11.State Key Laboratory for Infectious Diseases Prevention and Control,National Institute for Viral Disease Control and Pre-vention,Chinese Center for Disease Control and Prevention,Beijing 100052,China;2.School of Medicine,Xi’an Jiao-Tong University,Xi’an 710061,China;3.Tong-Ji Medica
[9]  
Stabilization of an E3 ligase‐E2‐ubiquitin complex increases cell surface MHC class I expression. Duncan LM,Nathan JA,Lehner PJ. J Immunol . 2010
[10]  
A novel anti‐prion protein monoclonal antibody and its single‐chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells. Shimizu Y,Kaku‐Ushiki Y,Iwamaru Y,et al. Microbiology and Immunology . 2010